Risk and prognosis of secondary bladder cancer after radiation therapy for pelvic cancer

BackgroundRadiation therapy (RT) is a crucial modality for the local control of pelvic cancer (PC), but the effect of pelvic RT on the development of secondary malignancy is still unclear. This study aimed to identify the relationship between radiation therapy received for the treatment of primary P...

Full description

Bibliographic Details
Main Authors: Shuofeng Li, Ran Wei, Guanhua Yu, Hengchang Liu, Tianli Chen, Xu Guan, Xishan Wang, Zheng Jiang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.982792/full
_version_ 1798037036606685184
author Shuofeng Li
Ran Wei
Guanhua Yu
Hengchang Liu
Tianli Chen
Xu Guan
Xishan Wang
Zheng Jiang
author_facet Shuofeng Li
Ran Wei
Guanhua Yu
Hengchang Liu
Tianli Chen
Xu Guan
Xishan Wang
Zheng Jiang
author_sort Shuofeng Li
collection DOAJ
description BackgroundRadiation therapy (RT) is a crucial modality for the local control of pelvic cancer (PC), but the effect of pelvic RT on the development of secondary malignancy is still unclear. This study aimed to identify the relationship between radiation therapy received for the treatment of primary PC and subsequent secondary bladder cancer (SBC).MethodsThe Surveillance, Epidemiology, and End Results (SEER) database (from 1975 to 2015) was queried for PC. Fine-gray competing risk regression and Cox regression analyses were employed to assess the cumulative incidence of SBC. Poisson regression and multiple primary standardized incidence ratios (SIR) were used to evaluate the radiotherapy-associated risk for patients receiving RT. Subgroup analyses of patients stratified by latency time since PC diagnosis, calendar year of PC diagnosis stage, and age at PC diagnosis were also performed. Overall survival (OS) was compared among different treatment groups with SBC by Kaplan–Meier analysis.ResultsA total of 318,165 observations showed that the primary cancers were located in pelvic cavity, 256,313 patients did not receive radiation therapy (NRT), 51,347 patients who underwent external beam radiation therapy (EBRT), and 10,505 patients receiving a combination of EBRT and brachytherapy (EBRT–BRT) who developed SBC. Receiving two types of radiotherapy was strongly consistent with a higher risk of developing SBC for PC patients in Fine-Gray competing risk regression (NRT vs. EBRT, adjusted HR= 1.71, 95% CI: 1.54-1.90, P<0.001; NRT vs. EBRT–BRT, adjusted HR= 2.16, 95% CI: 1.78-2.63, P<0.001). The results of the dynamic SIR and Poisson regression analysis for SBC revealed that a slightly increased risk of SBC was observed after RT in the early latency and was significantly related to the variations of age at PC diagnosis and decreased with time progress. For OS, the SBC after NRT, SBC after EBRT, and SBC after EBRT-BRT of 10-year survival rates were 37.9%, 29.2%, and 22.2%, respectively.ConclusionRadiotherapy for primary PC was associated with higher risks of developing SBC than patients unexposed to radiotherapy. Different pelvic RT treatment modalities had different effects on the risk of SBC.
first_indexed 2024-04-11T21:20:58Z
format Article
id doaj.art-5dd5c1909d6f4136b05f666a358a6926
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-04-11T21:20:58Z
publishDate 2022-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-5dd5c1909d6f4136b05f666a358a69262022-12-22T04:02:37ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-08-011210.3389/fonc.2022.982792982792Risk and prognosis of secondary bladder cancer after radiation therapy for pelvic cancerShuofeng LiRan WeiGuanhua YuHengchang LiuTianli ChenXu GuanXishan WangZheng JiangBackgroundRadiation therapy (RT) is a crucial modality for the local control of pelvic cancer (PC), but the effect of pelvic RT on the development of secondary malignancy is still unclear. This study aimed to identify the relationship between radiation therapy received for the treatment of primary PC and subsequent secondary bladder cancer (SBC).MethodsThe Surveillance, Epidemiology, and End Results (SEER) database (from 1975 to 2015) was queried for PC. Fine-gray competing risk regression and Cox regression analyses were employed to assess the cumulative incidence of SBC. Poisson regression and multiple primary standardized incidence ratios (SIR) were used to evaluate the radiotherapy-associated risk for patients receiving RT. Subgroup analyses of patients stratified by latency time since PC diagnosis, calendar year of PC diagnosis stage, and age at PC diagnosis were also performed. Overall survival (OS) was compared among different treatment groups with SBC by Kaplan–Meier analysis.ResultsA total of 318,165 observations showed that the primary cancers were located in pelvic cavity, 256,313 patients did not receive radiation therapy (NRT), 51,347 patients who underwent external beam radiation therapy (EBRT), and 10,505 patients receiving a combination of EBRT and brachytherapy (EBRT–BRT) who developed SBC. Receiving two types of radiotherapy was strongly consistent with a higher risk of developing SBC for PC patients in Fine-Gray competing risk regression (NRT vs. EBRT, adjusted HR= 1.71, 95% CI: 1.54-1.90, P<0.001; NRT vs. EBRT–BRT, adjusted HR= 2.16, 95% CI: 1.78-2.63, P<0.001). The results of the dynamic SIR and Poisson regression analysis for SBC revealed that a slightly increased risk of SBC was observed after RT in the early latency and was significantly related to the variations of age at PC diagnosis and decreased with time progress. For OS, the SBC after NRT, SBC after EBRT, and SBC after EBRT-BRT of 10-year survival rates were 37.9%, 29.2%, and 22.2%, respectively.ConclusionRadiotherapy for primary PC was associated with higher risks of developing SBC than patients unexposed to radiotherapy. Different pelvic RT treatment modalities had different effects on the risk of SBC.https://www.frontiersin.org/articles/10.3389/fonc.2022.982792/fullpelvic cancersecondary bladder cancerradiotherapyprognostic factoroverall survival (OS)
spellingShingle Shuofeng Li
Ran Wei
Guanhua Yu
Hengchang Liu
Tianli Chen
Xu Guan
Xishan Wang
Zheng Jiang
Risk and prognosis of secondary bladder cancer after radiation therapy for pelvic cancer
Frontiers in Oncology
pelvic cancer
secondary bladder cancer
radiotherapy
prognostic factor
overall survival (OS)
title Risk and prognosis of secondary bladder cancer after radiation therapy for pelvic cancer
title_full Risk and prognosis of secondary bladder cancer after radiation therapy for pelvic cancer
title_fullStr Risk and prognosis of secondary bladder cancer after radiation therapy for pelvic cancer
title_full_unstemmed Risk and prognosis of secondary bladder cancer after radiation therapy for pelvic cancer
title_short Risk and prognosis of secondary bladder cancer after radiation therapy for pelvic cancer
title_sort risk and prognosis of secondary bladder cancer after radiation therapy for pelvic cancer
topic pelvic cancer
secondary bladder cancer
radiotherapy
prognostic factor
overall survival (OS)
url https://www.frontiersin.org/articles/10.3389/fonc.2022.982792/full
work_keys_str_mv AT shuofengli riskandprognosisofsecondarybladdercancerafterradiationtherapyforpelviccancer
AT ranwei riskandprognosisofsecondarybladdercancerafterradiationtherapyforpelviccancer
AT guanhuayu riskandprognosisofsecondarybladdercancerafterradiationtherapyforpelviccancer
AT hengchangliu riskandprognosisofsecondarybladdercancerafterradiationtherapyforpelviccancer
AT tianlichen riskandprognosisofsecondarybladdercancerafterradiationtherapyforpelviccancer
AT xuguan riskandprognosisofsecondarybladdercancerafterradiationtherapyforpelviccancer
AT xishanwang riskandprognosisofsecondarybladdercancerafterradiationtherapyforpelviccancer
AT zhengjiang riskandprognosisofsecondarybladdercancerafterradiationtherapyforpelviccancer